BASULIN

medicines, namely, pharmaceutical preparations for use in treating all diseases linked to a lack and/or overloading in insulin for humans and animals, in particular diabetes; medicines containing insulin for use in treating all diseases linked to a lack and/or overloading in insulin for humans and animals, in particular diabetes; encapsulated form of insulin; encapsulated form of insulin with controlled and prolonged release; micro- or nano- capsules of insulin